Tandem Diabetes Care (TNDM) Current Assets (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Current Assets for 14 consecutive years, with $804.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets rose 30.87% year-over-year to $804.6 million; the trailing twelve-month figure through Jun 2026 stood at $804.6 million (up 30.87% YoY), and the FY2025 full-year result was $618.1 million, down 14.68% from the prior year.
• Current Assets retreated to $804.6 million in Q2 2026 per TNDM's latest filing, from $887.1 million in the prior quarter.
• Across five years, Current Assets topped out at $887.1 million in Q1 2026 and bottomed at $614.8 million in Q2 2025.
• Historically, Current Assets has averaged $751.0 million across 5 years, with a median of $755.4 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Current Assets retreated 18.05% in 2025, then jumped 33.71% in 2026.
• Over 5 years, Current Assets stood at $850.0 million in 2022, then retreated by 12.0% to $748.0 million in 2023, then slipped by 3.14% to $724.5 million in 2024, then slipped by 14.68% to $618.1 million in 2025, then jumped by 30.17% to $804.6 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $804.6 million, $887.1 million, and $618.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.